| 1 |
34427852 | Glycyrrhizic Acid Alleviates Lipopolysaccharide (LPS)-Induced Acute Lung Injury by Regulating Angiotensin-Converting Enzyme-2 (ACE2) and Caveolin-1 Signaling Pathway. | 2022 Feb |
1 |
| 2 |
34617194 | Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma. | 2022 May |
1 |
| 3 |
35432719 | Glycyrrhizin Attenuates Hypoxic-Ischemic Brain Damage by Inhibiting Ferroptosis and Neuroinflammation in Neonatal Rats via the HMGB1/GPX4 Pathway. | 2022 |
6 |
| 4 |
32602358 | Glycyrrhizin, an HMGB1 inhibitor, Suppresses Interleukin-1β-Induced Inflammatory Responses in Chondrocytes from Patients with Osteoarthritis. | 2021 Dec |
4 |
| 5 |
33107103 | HMGB1 as a therapeutic target in disease. | 2021 May |
1 |
| 6 |
33347772 | Effects of Glycyrrhizin Treatment on Diabetic Cornea. | 2021 Jan-Feb |
1 |
| 7 |
33611821 | Extracellular microvesicles promote microglia-mediated pro-inflammatory responses to ethanol. | 2021 Aug |
1 |
| 8 |
33773396 | Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication. | 2021 Jun |
1 |
| 9 |
34289368 | Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia. | 2021 Jul 20 |
2 |
| 10 |
34684184 | Targeting Inflammation Driven by HMGB1 in Bacterial Keratitis-A Review. | 2021 Sep 25 |
2 |
| 11 |
34739475 | HMGB1-antagonism exerted by glycyrrhizin could be fruitful against COVID-19. | 2021 Oct 1 |
2 |
| 12 |
34867338 | Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting. | 2021 |
2 |
| 13 |
34934826 | Glycyrrhizin and its derivatives promote hepatic differentiation via sweet receptor, Wnt, and Notch signaling. | 2021 Dec |
2 |
| 14 |
31769590 | Cigarette smoke-induced HMGB1 translocation and release contribute to migration and NF-κB activation through inducing autophagy in lung macrophages. | 2020 Jan |
1 |
| 15 |
31872339 | Glycyrrhizin Prevents Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke with Delayed Thrombolysis Through Targeting Peroxynitrite-Mediated HMGB1 Signaling. | 2020 Oct |
5 |
| 16 |
31916113 | Restoration of calcium-induced differentiation potential and tight junction formation in HaCaT keratinocytes by functional attenuation of overexpressed high mobility group box-1 protein. | 2020 Feb |
2 |
| 17 |
31924647 | Neuroimmune/Hematopoietic Axis with Distinct Regulation by the High-Mobility Group Box 1 in Association with Tachykinin Peptides. | 2020 Feb 15 |
2 |
| 18 |
32117622 | Glycyrrhizin suppresses epithelial-mesenchymal transition by inhibiting high-mobility group box1 via the TGF-β1/Smad2/3 pathway in lung epithelial cells. | 2020 |
6 |
| 19 |
32275943 | HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression. | 2020 Aug |
2 |
| 20 |
32340172 | Glycyrrhizin Inhibits PEDV Infection and Proinflammatory Cytokine Secretion via the HMGB1/TLR4-MAPK p38 Pathway. | 2020 Apr 23 |
2 |
| 21 |
32419317 | TNF-α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury. | 2020 Jun |
1 |
| 22 |
32523355 | Inhibition of HMGB1 Overcomes Resistance to Radiation and Chemotherapy in Nasopharyngeal Carcinoma. | 2020 |
3 |
| 23 |
32623356 | N-glycosylation of High Mobility Group Box 1 protein (HMGB1) modulates the interaction with glycyrrhizin: A molecular modeling study. | 2020 Oct |
2 |
| 24 |
32633407 | Glycyrrhizin improves inflammation and apoptosis via suppressing HMGB1 and PI3K/mTOR pathway in lipopolysaccharide-induced acute liver injury. | 2020 Jun |
1 |
| 25 |
32722545 | The Complex Relationship between Diabetic Retinopathy and High-Mobility Group Box: A Review of Molecular Pathways and Therapeutic Strategies. | 2020 Jul 26 |
1 |
| 26 |
32963505 | Beneficial Effects of Glycyrrhizin in Chronic Periodontitis Through the Inhibition of Inflammatory Response. | 2020 Jul-Sep |
2 |
| 27 |
33287126 | Role of HMGB1/TLR4 Axis in Ischemia/Reperfusion-Impaired Extracellular Glutamate Clearance in Primary Astrocytes. | 2020 Dec 3 |
1 |
| 28 |
33313438 | HMGB1 as a potential biomarker and therapeutic target for severe COVID-19. | 2020 Dec |
1 |
| 29 |
30634142 | Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis. | 2019 Mar |
2 |
| 30 |
30782274 | [Expression of high-mobility group box 1 in neonates with sepsis]. | 2019 Feb |
2 |
| 31 |
30832473 | Glycyrrhizin Attenuates the Process of Epithelial-to-Mesenchymal Transition by Modulating HMGB1 Initiated Novel Signaling Pathway in Prostate Cancer Cells. | 2019 Mar 27 |
6 |
| 32 |
31105713 | Dipotassium Glycyrrhizate Improves Intestinal Mucosal Healing by Modulating Extracellular Matrix Remodeling Genes and Restoring Epithelial Barrier Functions. | 2019 |
4 |
| 33 |
31190067 | Polyamine-stimulation of arsenic-transformed keratinocytes. | 2019 Aug 22 |
1 |
| 34 |
31336567 | High Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction. | 2019 Jul 22 |
2 |
| 35 |
31450620 | Antifibrotic Effects of High-Mobility Group Box 1 Protein Inhibitor (Glycyrrhizin) on Keloid Fibroblasts and Keloid Spheroids through Reduction of Autophagy and Induction of Apoptosis. | 2019 Aug 24 |
2 |
| 36 |
31497226 | Glycyrrhizin suppresses inflammation and cell apoptosis by inhibition of HMGB1 via p38/p-JUK signaling pathway in attenuating intervertebral disc degeneration. | 2019 |
7 |
| 37 |
31507379 | Detrimental Effects of HMGB-1 Require Microglial-Astroglial Interaction: Implications for the Status Epilepticus -Induced Neuroinflammation. | 2019 |
1 |
| 38 |
31545873 | Protective effect of glycyrrhizic acid on cerebral ischemia/reperfusion injury via inhibiting HMGB1-mediated TLR4/NF-κB pathway. | 2019 Nov |
3 |
| 39 |
29241031 | The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. | 2018 Feb |
2 |
| 40 |
29329282 | Induction of high-mobility group Box-1 in vitro and in vivo by respiratory syncytial virus. | 2018 May |
4 |
| 41 |
29436639 | Glycyrrhizin affects monocyte migration and apoptosis by blocking HMGB1 signaling. | 2018 Apr |
6 |
| 42 |
29448108 | Inhibition of HMGB1 mediates neuroprotection of traumatic brain injury by modulating the microglia/macrophage polarization. | 2018 Feb 26 |
5 |
| 43 |
29568761 | Glycyrrhizin Suppresses the Growth of Human NSCLC Cell Line HCC827 by Downregulating HMGB1 Level. | 2018 |
3 |
| 44 |
29676481 | High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches. | 2018 Aug |
1 |
| 45 |
29763588 | Glycyrrhizin ameliorates inflammatory pain by inhibiting microglial activation-mediated inflammatory response via blockage of the HMGB1-TLR4-NF-kB pathway. | 2018 Aug 1 |
2 |
| 46 |
29795370 | HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA. | 2018 May 24 |
2 |
| 47 |
30061484 | Inhibition of Homophilic Interactions and Ligand Binding of the Receptor for Advanced Glycation End Products by Heparin and Heparin-Related Carbohydrate Structures. | 2018 Jul 30 |
2 |
| 48 |
30119194 | The protective effect of formononetin on cognitive impairment in streptozotocin (STZ)-induced diabetic mice. | 2018 Oct |
3 |
| 49 |
30325653 | Glycyrrhizin, a Potential Drug for Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1. | 2018 Dec |
3 |
| 50 |
30587909 | Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study. | 2018 |
1 |